Heron Therapeutics, Inc. (HRTX) vs MediciNova, Inc. (MNOV)
- Heron Therapeutics, Inc. HRTX 0.36 −5.26%
- MediciNova, Inc. MNOV 1.42 −2.07%
Heron Therapeutics, Inc. and MediciNova, Inc. are both Biotechnology companies. Heron Therapeutics, Inc. and MediciNova, Inc. are of similar size ($71.5M and $71.4M). Heron Therapeutics, Inc. grew revenue faster over the last twelve months: 0.99% against −82.2%. Heron Therapeutics, Inc. has the higher net margin (−22.5% vs −1,168.3%) and the higher return on invested capital (−6.35% vs −62.5%). Across the 17 metrics below, Heron Therapeutics, Inc. leads on 11 and MediciNova, Inc. on 6.
Valuation
Profitability
| Metric | HRTX | MNOV | Biotechnology median |
|---|---|---|---|
| Gross margin | 70.07% | 37.76% | 65.16% |
| Operating margin | (7.19%) | (1,287.53%) | 0.00% |
| Net margin | (22.52%) | (1,168.31%) | 0.00% |
| Free cash flow margin | (8.00%) | (991.31%) | 0.00% |
| Return on equity | 318.21% | (25.56%) | (56.36%) |
| Return on assets | (14.06%) | (23.83%) | (48.04%) |
| Return on invested capital | (6.35%) | (62.48%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack